Our expertise lies in neuromodulation techniques that address specific neuropathic pain conditions and neurodegenerative diseases. By employing optogenetic approaches, we aim to dissect neural circuitry, providing insights that can potentially lead to groundbreaking advancements in the field.
We specialize in conducting preclinical studies focused on conditions like trigeminal neuralgia and peripheral nerve injury. Through the application of optogenetic paradigms, we seek to gather comprehensive insights into the underlying neurobiological mechanisms, offering potential avenues for novel therapeutic interventions.
Our commitment extends to neurodegenerative diseases such as Parkinson's and Huntington's disease. By utilizing optogenetic tools, we aim to elucidate the intricate neural pathways involved in these conditions, with the ultimate goal of contributing to the development of targeted therapies and improved patient outcomes.
At the core of our research is the utilization of optogenetic approaches. We leverage this cutting-edge technology to manipulate and observe neural activity with unprecedented precision, providing a deeper understanding of the neural circuits implicated in various neurological disorders.